![](/blulogo.gif) |
The 130th Annual Meeting of APHA |
2009.0: Sunday, November 10, 2002 - 10:50 AM
Abstract #52686
Effects of Pharmaceutical Industry/Academia Collaboration
Martin T. Donahoe, MD FACP, Center for Ethics in Health Care, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, N/A, anna.keller@apha.org
Learning Objectives:
- Assess the role of industry in funding basic science and clinical investigation related to drug development.
- Articulate ethical issues which arise consequent to increasing links between academia and industry.
- Develop recommendations for effective investigator-industry, policy maker-industry, and provider-industry relationships.
- Articulate ways in which health professionals can work collaboratively with industry to benefit patients.
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.
Pharmaceutical Industry: Phacts & Phiction for Public Health Professionals
The 130th Annual Meeting of APHA